Clinical Trial Update: Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial completed evaluating prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving highly emetogenic cisplatin-ba…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nausea and Vomiting, Chemotherapy-Induced | Phase 2 | Status: COMPLETED